101858-69-9

Basic information

• Product Name: 2-[2-[2-(1,3-dioxoisoindol-2-yl)ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate
• Synonyms: 2-[2-[2-(1,3-dioxoisoindol-2-yl)ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate
• CAS NO: 101858-69-9
• Molecular Weight: 433.482
• Mol File: 101858-69-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-[2-[2-(1,3-dioxoisoindol-2-yl)ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[2-[2-(1,3-dioxoisoindol-2-yl)ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate(101858-69-9)
• EPA Substance Registry System: 2-[2-[2-(1,3-dioxoisoindol-2-yl)ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate(101858-69-9)

Safety Data

• Hazardous Substances Data: 101858-69-9(Hazardous Substances Data)

Upstream product

• 1074-82-4 potassium phtalimide 
• 6338-55-2 2-(2-(2-aminoethoxy)ethoxy)ethan-1-ol 
• 85-44-9 phthalic anhydride 
• 5197-62-6 2-[2-(chloroethoxy)ethoxy]ethanol 
• 75001-08-0 2-{2-[2-(2-hydroxyethoxy)ethoxy]ethyl}isoindole-1,3-dione 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 888009-95-8 2-{2-[2-(2-{4-[(2-{2-[2-(4-methylbenzenesulfonyl)ethoxy]ethoxy}ethoxy)methyl]-1H-1,2,3-triazol-1-yl}ethoxy)ethoxy]ethyl}isoindoline-1,3-dione 
• 888009-99-2 C₄₈H₆₈N₁₀O₁₆S 
• 888009-97-0 2-[2-(2-{2-[4-({2-[2-(2-{4-[(2-{2-[2-(4-methylbenzenesulfonyl)ethoxy]ethoxy}ethoxy)methyl]-1H-1,2,3-triazol-1-yl}ethoxy)ethoxy]ethoxy}methyl)-1H-1,2,3-triazol-1-yl]ethoxy}ethoxy)ethyl]isoindoline-1,3-dione 

Relevant articles and documents

An iterative route to "decorated" ethylene glycol-based linkers

Iterative copper-catalyzed cycloadditions of azides to alkynes were used to join functionalized triethylene glycol molecules to give "linkers" of defined lengths equipped with several different end-group functionalities. The Royal Society of Chemistry 200

MDM2 DEGRADERS AND USES THEREOF

The present invention relates to compounds and methods useful for the modulation of mouse double minute 2 homolog ("MDM2") protein via ubiquitination and/or degradation by compounds according to the present invention.

Investigation of the structural requirements for the κ-selective opioid receptor antagonist, 6β,6β'-[ethylenebis(oxyethyleneimino)]bis[17-(cyclopropylmethyl)-4,5α-e poxymorphinan-3,14-diol] (TENA)

-